These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2113587)

  • 1. Crystallization and preliminary X-ray diffraction study of the bacterially expressed Fv from the monoclonal anti-lysozyme antibody D1.3 and of its complex with the antigen, lysozyme.
    Boulot G; Eiselé JL; Bentley GA; Bhat TN; Ward ES; Winter G; Poljak RJ
    J Mol Biol; 1990 Jun; 213(4):617-9. PubMed ID: 2113587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystallization and preliminary X-ray diffraction study of an idiotope-anti-idiotope Fv-Fv complex.
    Goldbaum FA; Fields BA; Cauerhff A; Ysern X; Houdusse A; Eisele JL; Poljak RJ; Mariuzza RA
    J Mol Biol; 1994 Sep; 241(5):739-43. PubMed ID: 8071997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystallization and preliminary X-ray studies of the VL domain of the antibody McPC603 produced in Escherichia coli.
    Glockshuber R; Steipe B; Huber R; Plückthun A
    J Mol Biol; 1990 Jun; 213(4):613-5. PubMed ID: 2113586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystallization, preliminary X-ray diffraction study, and crystal packing of a complex between anti-hen lysozyme antibody F9.13.7 and guinea-fowl lysozyme.
    Lescar J; Riottot MM; Souchon H; Chitarra V; Bentley GA; Navaza J; Alzari PM; Poljak RJ
    Proteins; 1993 Feb; 15(2):209-12. PubMed ID: 7680133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Domain interactions and antigen binding of recombinant anti-Z-DNA antibody variable domains. The role of heavy and light chains measured by surface plasmon resonance.
    Polymenis M; Stollar BD
    J Immunol; 1995 Mar; 154(5):2198-208. PubMed ID: 7868893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystallization of single-chain Fv proteins.
    Essig NZ; Wood JF; Howard AJ; Raag R; Whitlow M
    J Mol Biol; 1993 Dec; 234(3):897-901. PubMed ID: 8254684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The de novo design of an antibody combining site. Crystallographic analysis of the VL domain confirms the structural model.
    Essen LO; Skerra A
    J Mol Biol; 1994 Apr; 238(2):226-44. PubMed ID: 8158652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small rearrangements in structures of Fv and Fab fragments of antibody D1.3 on antigen binding.
    Bhat TN; Bentley GA; Fischmann TO; Boulot G; Poljak RJ
    Nature; 1990 Oct; 347(6292):483-5. PubMed ID: 2215663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli.
    Ward ES; Güssow D; Griffiths AD; Jones PT; Winter G
    Nature; 1989 Oct; 341(6242):544-6. PubMed ID: 2677748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contributions of immunoglobulin heavy and light chains to antibody specificity for lysozyme and two haptens.
    Smith-Gill SJ; Hamel PA; Lovoie TB; Dorrington KJ
    J Immunol; 1987 Dec; 139(12):4135-44. PubMed ID: 2447160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant antineuraminidase single chain antibody: expression, characterization, and crystallization in complex with antigen.
    Malby RL; Caldwell JB; Gruen LC; Harley VR; Ivancic N; Kortt AA; Lilley GG; Power BE; Webster RG; Colman PM
    Proteins; 1993 May; 16(1):57-63. PubMed ID: 8497484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VL-VH expression by monoclonal antibodies recognizing avian lysozyme.
    Smith-Gill SJ; Mainhart CR; Lavoie TB; Rudikoff S; Potter M
    J Immunol; 1984 Feb; 132(2):963-7. PubMed ID: 6418816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleotide sequence of the VH, VL regions of an anti-idiotopic antibody reacting with a private idiotope of the anti-lysozyme D1.3 antibody.
    Souchon H; Doyen N; Riottot MM; Rougeon F; Poljak RJ
    Mol Immunol; 1990 May; 27(5):429-33. PubMed ID: 1973259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling.
    Eigenbrot C; Randal M; Presta L; Carter P; Kossiakoff AA
    J Mol Biol; 1993 Feb; 229(4):969-95. PubMed ID: 8095303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystals of an antibody Fv fragment against an integral membrane protein diffracting to 1.28 A resolution.
    Ostermeier C; Essen LO; Michel H
    Proteins; 1995 Jan; 21(1):74-7. PubMed ID: 7716172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Construction and expression of single chain Fv antibody against human bladder carcinoma].
    Zhang M; Yu L; Huang H
    Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):792-5. PubMed ID: 16201198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage specificity of a proteolytic antibody light chain and effects of the heavy chain variable domain.
    Sun M; Gao QS; Kirnarskiy L; Rees A; Paul S
    J Mol Biol; 1997 Aug; 271(3):374-85. PubMed ID: 9268666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cloning and expression of heavy- and light-chain variable region genes of monoclonal antibody specific for human fibrin].
    Song Z; Cai Y; Song D; Xu J; Wang L; Yuan H; Liu J; Zhang Y; Lin H
    Zhonghua Xue Ye Xue Za Zhi; 1997 Jun; 18(6):311-4. PubMed ID: 15622627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the immunoglobulin heavy chain locus on expression of the VK1GAC light chain.
    Fulton RJ; Davie JM
    J Immunol; 1984 Jul; 133(1):465-70. PubMed ID: 6427345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a humanised single chain Fv (Scfv) derived from the monoclonal Eric-1 recognising the human neural cell adhesion molecule.
    Whittington HA; Hancock J; Kemshead JT
    Med Pediatr Oncol; 2001 Jan; 36(1):243-6. PubMed ID: 11464896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.